Release Date: 19/06/13 09:03 Summary: Special Distribution and Fund Update Price Sensitive: Yes Download Document 135.71KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%